Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus

Somatostatin analogs mantain their major role in the treatment of patients with advanced neuroendocrine tumors (NETs) and have multiple modulatory effects on the immune system. Here, we evaluated the effects of lanreotide treatment on expression of Th1, Th2 cytokine patterns in serum of patients wit...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Sciammarella, Concetta, Luce, Amalia, Riccardi, Ferdinando, Mocerino, Carmela, Modica, Roberta, Berretta, Massimiliano, Misso, Gabriella, Cossu, Alessia Maria, Colao, Annamaria, Vitale, Giovanni, Necas, Alois, Fedacko, Jan, Galdiero, Marilena, Correale, Pierpaolo, Faggiano, Antongiulio, Caraglia, Michele, Capasso, Anna, Grimaldi, Anna
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379869/
https://ncbi.nlm.nih.gov/pubmed/32766136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01047
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы